About: Varlilumab

An Entity of Type: monoclonal antibody, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Varlilumab (INN; development code CDX-1127) is a monoclonal antibody designed for immunotherapy for solid tumors and hematologic malignancies. It is an anti-CD27 antibody and helps activate T-cells. This drug was developed by Celldex Therapeutics. It (in combination with ONT-10) has undergone a phase 1B clinical trial for advanced breast or ovarian cancer. In combination with anti-PD-1 nivolumab it has undergone a phase 1/2 trial for advanced refractory solid tumours

Property	Value
dbo:abstract	Varlilumab (INN; development code CDX-1127) is a monoclonal antibody designed for immunotherapy for solid tumors and hematologic malignancies. It is an anti-CD27 antibody and helps activate T-cells. This drug was developed by Celldex Therapeutics. It (in combination with ONT-10) has undergone a phase 1B clinical trial for advanced breast or ovarian cancer. In combination with anti-PD-1 nivolumab it has undergone a phase 1/2 trial for advanced refractory solid tumours (en)
dbo:casNumber	1393344-72-3
dbo:fdaUniiCode	0125DUV5XC
dbo:wikiPageID	46624845 (xsd:integer)
dbo:wikiPageLength	2716 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1062269038 (xsd:integer)
dbo:wikiPageWikiLink	dbr:CD27 dbr:ONT-10 dbr:Monoclonal_antibody dbr:Nivolumab dbr:International_Nonproprietary_Name dbc:Monoclonal_antibodies dbr:Immunotherapy dbr:T-cell_activation
dbp:atcPrefix	none (en)
dbp:c	6486 (xsd:integer)
dbp:casNumber	1393344 (xsd:integer)
dbp:chemspiderid	none (en)
dbp:h	9992 (xsd:integer)
dbp:n	1740 (xsd:integer)
dbp:o	2022 (xsd:integer)
dbp:s	42 (xsd:integer)
dbp:source	u (en)
dbp:synonyms	CDX-1127 (en)
dbp:target	dbr:CD27
dbp:type	mab (en)
dbp:unii	125 (xsd:integer)
dbp:wikiPageUsesTemplate	dbt:Drugbox dbt:Reflist dbt:Short_description dbt:Fdacite dbt:Cytokine_receptor_modulators dbt:Monoclonals_for_immune_system dbt:Monoclonal-antibody-stub
dct:subject	dbc:Monoclonal_antibodies
gold:hypernym	dbr:Antibody
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:MonoclonalAntibody dbo:Drug
rdfs:comment	Varlilumab (INN; development code CDX-1127) is a monoclonal antibody designed for immunotherapy for solid tumors and hematologic malignancies. It is an anti-CD27 antibody and helps activate T-cells. This drug was developed by Celldex Therapeutics. It (in combination with ONT-10) has undergone a phase 1B clinical trial for advanced breast or ovarian cancer. In combination with anti-PD-1 nivolumab it has undergone a phase 1/2 trial for advanced refractory solid tumours (en)
rdfs:label	Varlilumab (en)
owl:sameAs	freebase:Varlilumab wikidata:Varlilumab https://global.dbpedia.org/id/212xb yago-res:Varlilumab
prov:wasDerivedFrom	wikipedia-en:Varlilumab?oldid=1062269038&ns=0
foaf:isPrimaryTopicOf	wikipedia-en:Varlilumab
is dbo:wikiPageWikiLink of	dbr:Primary_cutaneous_diffuse_large_B-cell_lymphoma,_leg_type dbr:Renal_cell_carcinoma dbr:CD27 dbr:Diffuse_large_B-cell_lymphoma_associated_with_chronic_inflammation dbr:List_of_therapeutic_monoclonal_antibodies
is foaf:primaryTopic of	wikipedia-en:Varlilumab